What are the recommended medications for allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Allergies

Severity-Based Treatment Algorithm

For mild allergic symptoms (itching, urticaria, rhinorrhea), second-generation H1 antihistamines are the preferred first-line treatment, with cetirizine 10 mg once daily or loratadine 10 mg once daily being optimal choices due to their rapid onset, minimal sedation, and proven efficacy. 1, 2

Mild Allergic Reactions (Urticaria, Itching, Mild Rhinitis)

Preferred medications:

  • Cetirizine 10 mg once daily - fastest onset among second-generation antihistamines with minimal sedation 2
  • Loratadine 10 mg once daily - onset within 1 hour, duration of at least 24 hours 1, 3
  • Fexofenadine 180 mg once daily - completely non-sedating with no psychomotor impairment 2

Avoid first-generation antihistamines (diphenhydramine, chlorpheniramine) as primary therapy due to significant sedation, cognitive impairment, anticholinergic effects, and association with accidents and cardiac events 1, 4

Allergic Rhinitis

Treatment escalation based on symptom severity:

  • Mild intermittent symptoms: Second-generation H1 antihistamines as needed 1
  • Consistent mild-moderate symptoms: Intranasal corticosteroids (INCS) as monotherapy 1
  • Moderate persistent symptoms: Daily INCS as preferred controller medication 1
  • Severe symptoms: Combination therapy with INCS plus oral antihistamine and/or leukotriene receptor antagonist 1

Intranasal antihistamines (azelastine) are equal or superior to oral second-generation antihistamines for seasonal allergic rhinitis and can be used as first-line treatment 1

Anaphylaxis - Life-Threatening Allergic Reactions

This is the critical distinction where treatment differs dramatically from mild allergies:

First-line treatment (NO substitutes):

  • Epinephrine 0.3-0.5 mg intramuscularly (anterolateral thigh) for adults and children >25 kg 5, 6
  • Epinephrine 0.01 mg/kg IM (maximum 0.3 mg) for children ≤25 kg 5, 6
  • Repeat every 5-15 minutes as necessary 5, 6

Adjunctive medications (never substitute for epinephrine):

  • H1 antihistamines: Diphenhydramine 1-2 mg/kg (maximum 50 mg) IV/oral OR cetirizine 10 mg for less sedation 5, 1, 2
  • H2 antihistamines: Ranitidine 1-2 mg/kg (maximum 75-150 mg) 5
  • Corticosteroids: Prednisone 1 mg/kg (maximum 60-80 mg) oral or methylprednisolone 1 mg/kg IV to prevent biphasic reactions 5
  • Bronchodilators: Albuterol nebulized (1.5 mL children, 3 mL adults) for bronchospasm 5

Critical Pitfalls to Avoid

The most dangerous error is using antihistamines instead of epinephrine for anaphylaxis. Antihistamines only relieve itching and urticaria - they do NOT treat stridor, shortness of breath, wheezing, GI symptoms, hypotension, or shock 5. Antihistamines reach peak concentration in 1-3 hours versus <10 minutes for IM epinephrine 7.

Never inject epinephrine into buttocks, digits, hands, or feet - only anterolateral thigh 6

First-generation antihistamines cause significant sedation and may decrease awareness of worsening anaphylaxis symptoms 5

Discharge and Long-Term Management

After anaphylaxis treatment:

  • Prescribe two epinephrine auto-injectors with proper training 5, 1
  • Continue adjunctive therapy for 2-3 days: H1 antihistamine every 6 hours, H2 antihistamine twice daily, corticosteroid daily 5
  • Provide written anaphylaxis emergency action plan 5
  • Refer to allergist for comprehensive evaluation 5, 1

Immunotherapy Consideration

For persistent symptoms despite optimal pharmacotherapy, allergen immunotherapy (subcutaneous or sublingual) should be considered when there is clear evidence of specific IgE sensitization to clinically relevant allergens 1

References

Guideline

Allergy Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Loratadine: a nonsedating antihistamine with once-daily dosing.

DICP : the annals of pharmacotherapy, 1989

Research

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

The Journal of allergy and clinical immunology, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.